<DOC>
	<DOCNO>NCT03025399</DOCNO>
	<brief_summary>This study include 384 Participants diabetic non-proliferative retinopathy Design Method : Randomized , double blind , placebo control multicenter clinical study . Participants treatment 48 week , main aim evaluate therapeutic effect tang wang prescription improve degree retinal microvascular disease patient diabetic non-proliferative retinopathy .</brief_summary>
	<brief_title>Clinical Study Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy</brief_title>
	<detailed_description>1 . This study randomize , double-blinded , placebo-controlled multicenter clinical trial type 2 diabetic non-proliferative retinopathy evaluate therapeutic effect tang wang prescription . 2 . Through calculation sample size , 384 participant type 2 diabetic non-proliferative retinopathy recruit study , participant randomly divide 2 group , group would perform basic treatment ( include diabetes education , diabetes diet , rational control blood glucose ( oral hypoglycemic agent insulin injection keep participant keep blood glucose stable study . If fasting blood glucose fluctuate 20 % , need find remove factor soon possible , adjust dose monitor change blood glucose , make smooth 4 week . Adjusted dose drug need detailed record combine medication table ) , oral calcium dobesilate treatment ) , study group take tang wang prescription , take one bag time twice day , control group take dose placebo . 3 . The study last 48 week . Once every four week follow-up , color fundus photography , fundus fluorescein angiography , coherent optical tomography perform every six month ; ETDRS international visual acuity test perform every month . 4 . Curative effect evaluation criterion : - Main evaluation criterion : change degree retinal microvascular lesion treatment , accord change degree retinal microvascular lesion ( , mild non proliferative phase , moderate non proliferative phase , severe non proliferative phase , proliferative phase ) , divide aggravate , unchanged , reduce three condition . Aggravated define degree retinal microvascular lesion severity grade 1 treatment ; unchanged define degree retinal microvascular lesion treatment change ; reduce define degree retinal microvascular lesion reduce 1 grade treatment . - Second evaluation criterion : - Change number micro hemangioma diabetic retinopathy treatment ; - Change number microvascular bleed diabetic retinopathy treatment ; - Change number microvascular leakage diabetic retinopathy treatment ; - Degree change macular edema diabetic retinopathy treatment ; - Change Vision treatment . 5 . Diagnostic monitoring indicators：blood pressure , fast blood glucose test ( every one month ) ; glycated hemoglobin , blood lipid ( every three month ) ; Routine eye examination fundus examination , include intraocular pressure , anterior segment , lens , vitreous body , lens , vitreous need describe condition opacity ( every six month ) . 6 . The provision combine therapy - All Chinese herbal medicine efficacy study drug ( include Chinese herbal medicine similar therapeutic similar efficacy Instructions ) ban study period . - All combined therapy Combined medication ( treatment measure treatment medicine disease ) record combined medication table .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>1 . Diagnosis diabetic retinopathy、the degree disease nonproliferative diabetic retinopathy； 2 . Age 3070 year old； 3 . Signed informed consent； Note : Diabetic retinopathy patient select observation object , Who one eye meet inclusion criterion , If eyes patient select , please record respectively , choose one eye evaluate curative effect , eye must accord follow principle : choose heavy eye observation eye , When fundus condition eye different clinical stage ; Select eye eye clinical manipulation . Choose eye well clinical operation observation eye , When fundus condition eye clinical stage . 1 . The patient retinal photocoagulation、appropriate patient retinal photocoagulation、patient one two eye diabetic retinopathy proliferative phase、type I diabetes mellitus、there eye disease complication ( glaucoma、cataracts Significantly interfere fundus examination、Non diabetic retinopathy、uveitis、amotio retinae、optic nerve disease high myopia fundus lesion et al . ) 2 . Combined severe primary disease cardiovascular、liver、kidney hematopoietic system et al、the serum transaminase 2 time large normal valuet、Serum creatinine great upper limit normal value、Psychiatric patient . 3 . Women Pregnancy prepare pregnancy lactate . 4 . Patient participate clinical researcher within month . 5 . Patients treat drug treat diabetic retinopathy except calcium hydroxide within week . 6 . Systolic blood pressure &gt; 160mmHg diastolic blood pressure &gt; 100mmHg . 7 . Patients diabetic ketosis , ketoacidosis severe infection within month 8 . Patients alcohol abused / use psychoactive substance drug abuse drug addict within 5 year . 9 . According researcher 's judgment , patient Other lesion condition maybe reduce possibility enter group make group complex , work environment change frequently、Living environment unstable easy cause loss followup .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>tang wang prescription</keyword>
</DOC>